HIV-1 matrix protein p17 increases the production of proinflammatory cytokines and counteracts IL-4 activity by binding to a cellular receptor

Proc Natl Acad Sci U S A. 2002 Jul 23;99(15):9972-7. doi: 10.1073/pnas.142274699. Epub 2002 Jul 8.

Abstract

Purified recombinant HIV-1 p17 matrix protein significantly increased HIV-1 replication in preactivated peripheral blood mononuclear cell cultures obtained from healthy donors. Because HIV-1 infection and replication is related to cell activation and differentiation status, in the present study, we investigated the role played by p17 during the process of T cell stimulation. Using freshly isolated peripheral blood mononuclear cells, we demonstrate that p17 was able to enhance levels of tumor necrosis factor alpha and IFN-gamma released from cells stimulated by IL-2. IL-4 was found to down-regulate IFN-gamma and tumor necrosis factor alpha, and p17 restored the ability of cells to produce both cytokines. The property of p17 to increase production of proinflammatory cytokines could be a mechanism exploited by the virus to create a more suitable environment for HIV-1 infection and replication. Our data show that p17 exerts its biological activity after binding to a specific cellular receptor expressed on activated T lymphocytes. The functional p17 epitope involved in receptor binding was found to be located at the NH(2)-terminal region of viral protein. Immunization of BALB/c mice with a 14-aa synthetic peptide representative of the HIV-1 p17 functional region (SGGELDRWEKIRLR) resulted in the development of p17 neutralizing antibodies capable of blocking the interaction between p17 and its cellular receptor. Our results define a role for p17 in HIV-1 pathogenesis and contribute to our understanding of the molecular mechanism of HIV-1 infection and the development of additional antiviral therapeutic strategies.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Sequence
  • Animals
  • Cells, Cultured
  • Cytokines / genetics*
  • Gene Expression Regulation / immunology
  • Gene Products, gag / pharmacology*
  • HIV Antigens / pharmacology*
  • HIV-1 / physiology*
  • Humans
  • Interferon-gamma / metabolism
  • Interleukin-2 / pharmacology
  • Interleukin-4 / antagonists & inhibitors*
  • Kinetics
  • Lymphocyte Activation
  • Lymphocytes / drug effects
  • Lymphocytes / immunology*
  • Lymphocytes / virology
  • Mice
  • Molecular Sequence Data
  • Peptide Fragments / chemistry
  • Receptors, Cell Surface / immunology
  • Reference Values
  • Viral Proteins*
  • Virus Replication
  • gag Gene Products, Human Immunodeficiency Virus

Substances

  • Cytokines
  • Gene Products, gag
  • HIV Antigens
  • Interleukin-2
  • Peptide Fragments
  • Receptors, Cell Surface
  • Viral Proteins
  • gag Gene Products, Human Immunodeficiency Virus
  • p17 protein, Human Immunodeficiency Virus Type 1
  • Interleukin-4
  • Interferon-gamma